Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14379-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14379-1-AP, RRID:AB_2166330
- Product name
- PON2 antibody
- Antibody type
- Polyclonal
- Description
- PON2 antibody (Cat. #14379-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IF, IHC, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references GYY4137, a H(2)S donor, ameliorates kidney injuries in diabetic mice by modifying renal ROS-associated enzymes.
Paraoxonase 2 (PON2) Deficiency Reproduces Lipid Alterations of Diabetic and Inflammatory Glomerular Disease and Affects TRPC6 Signaling.
Breaking the chain at the membrane: paraoxonase 2 counteracts lipid peroxidation at the plasma membrane.
Expression of myocilin mutants sensitizes cells to oxidative stress-induced apoptosis: implication for glaucoma pathogenesis.
Chen X, Xiao L, Yu S, Ren Z, Wang W, Jia Y, Liu M, Wang P, Ji D, Yu Y, Wang X
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 Jun;162:114694
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 Jun;162:114694
Paraoxonase 2 (PON2) Deficiency Reproduces Lipid Alterations of Diabetic and Inflammatory Glomerular Disease and Affects TRPC6 Signaling.
Hagmann H, Khayyat NH, Oezel C, Papadakis A, Kuczkowski A, Benzing T, Gulbins E, Dryer S, Brinkkoetter PT
Cells 2022 Nov 16;11(22)
Cells 2022 Nov 16;11(22)
Breaking the chain at the membrane: paraoxonase 2 counteracts lipid peroxidation at the plasma membrane.
Hagmann H, Kuczkowski A, Ruehl M, Lamkemeyer T, Brodesser S, Horke S, Dryer S, Schermer B, Benzing T, Brinkkoetter PT
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2014 Apr;28(4):1769-79
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2014 Apr;28(4):1769-79
Expression of myocilin mutants sensitizes cells to oxidative stress-induced apoptosis: implication for glaucoma pathogenesis.
Joe MK, Tomarev SI
The American journal of pathology 2010 Jun;176(6):2880-90
The American journal of pathology 2010 Jun;176(6):2880-90
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human liver tissue were subjected to SDS PAGE followed by western blot with 14379-1-AP(PON2 antibody) at dilution of 1:300
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using PON2 antibody 14379-1-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red). Blue pseudocolor = DAPI (fluorescent DNA dye).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human liver cancer using 14379-1-AP(PON2 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human liver cancer using 14379-1-AP(PON2 antibody) at dilution of 1:50 (under 40x lens)
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PON2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PON2. This antibody recognizes human antigen. The PON2 antibody has been validated for the following applications: ELISA, WB, IHC, IF, FC analysis.